Disrupting Treatment of Cardiovascular Disease with Epigenetics: Resverlogix CEO Donald McCaffrey Oct 20, 2015 Technology
Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital’s Eden Rahim Aug 18, 2015 Technology